 |
 |
 |
|
|
| Name |
Location |
Funded from |
| AkaRx Inc. |
Paramus, NJ, USA |
AVC |
| Alba Therapeutics Corporation |
Baltimore, MD, USA |
FITE-I/II |
| Cellzome |
Heidelberg, Germany |
AVC |
| Ception Therapeutics |
Malvern, PA, USA |
FITE-I/II |
| CoMentis,Inc. |
South San Francisco, CA, USA |
FITE-I/II |
| Evolva SA |
Basel, Switzerland |
AVC |
| F2G Ltd |
Manchester, UK |
AVF I |
| FASgen, Inc. |
Baltimore, MD, USA |
FITE-I/II |
| Inimex Pharmaceuticals Inc. |
Burnaby, BC Canada |
AVF I |
| Lectus Therapeutics |
Cambridge, UK |
AVF I |
| Linden Bioscience |
Woburn, MA, USA |
FITE-I/II |
| Nereus Pharmaceuticals |
San Diego, CA, USA |
AVF I |
| Neuronautics, Inc. |
Highland Park, IL, USA |
FITE-I/II |
| PhysioGenix, Inc. |
Wauwatosa, WI, USA |
FITE-I/II |
| Plexxikon Inc. |
Berkely, CA |
AVC |
| Prolysis Limited |
Oxfordshire, UK |
FITE-I/II |
| Renovar Incorporated |
Madison, WI, USA |
FITE-I/II |
| Revivicor, Inc |
Blacksburg, VA, USA |
FITE-I/II |
| TaiGen Biotechnology Co., Ltd. |
Taipei, Taiwan |
FITE-I/II |
| Viamet Pharmaceuticals, Inc. |
Durham, NC. USA |
AVF I |
|
 |
|
|
 |
 |
 |